Canaccord lowered the firm’s price target on UiPath (PATH) to $15 from $19 and keeps a Buy rating on the shares. The firm said UiPath delivered a strong finish to fiscal 2026, and the quarter reinforces the thesis that UiPath’s decision to lean into agentic automation and orchestration is gaining commercial traction.
Claim 55% Off TipRanks
Trade PATH with leveragePublished first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PATH:
- UiPath price target lowered to $17 from $19 at Morgan Stanley
- UiPath price target lowered to $13 from $17 at UBS
- UiPath Delivers First Full-Year Profit and New Buyback
- Closing Bell Movers: Netscope down 17%, UiPath down 5% on earnings
- UiPath raises long-term operating margin target to 30% from above 20%